Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Serina Therapeutics, Inc. (SER) had Operating Cash Flow per Share of $-0.44 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.81M |
|
-- |
|
-- |
|
$5.86M |
|
$-5.86M |
|
$1.04M |
|
$-4.82M |
|
$-4.82M |
|
$-4.82M |
|
$-4.82M |
|
$-4.82M |
|
$-4.82M |
|
$-5.86M |
|
$-5.84M |
|
9.76M |
|
9.76M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$5.75M |
|
$0.48M |
|
$0.98M |
|
$6.73M |
|
$2.35M |
|
-- |
|
$2.82M |
|
$5.17M |
|
$1.56M |
|
$1.56M |
|
$1.56M |
|
9.93M |
|
| Cash Flow Statement Financials | |
$-4.32M |
|
-- |
|
$4.92M |
|
$3.67M |
|
$4.27M |
|
$0.59M |
|
$0.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-309.30% |
|
-309.30% |
|
-71.64% |
|
-309.30% |
|
$0.16 |
|
$-0.44 |
|
|
Operating Cash Flow per Share |
$-0.44 |